DTC Ad Comparative Claims Draw FDA Criticism, Even With “Scientific Basis”

“We’re not pleased with the way direct-to-consumer advertising is going,” Acting Commissioner Crawford says. DTC ads have become “ridiculous,” he says; “very strong measures” by FDA may be warranted.

More from Archive

More from Pink Sheet